Sciences, Metropolitan Autonomous University. Mexico City, Mexico.
Department of Neurochemistry, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez. Mexico City, Mexico.
Spine (Phila Pa 1976). 2021 Oct 1;46(19):1287-1294. doi: 10.1097/BRS.0000000000004015.
Prospective longitudinal experimental study.
We evaluate the effect of dapsone on tactile allodynia and mechanical hyperalgesia and to determine its anti-oxidant effect in a spinal cord injury (SC) model in rats.
Neuropathic pain (NP) as result of traumatic spinal cord injury is a deleterious medical condition with temporal or permanent time-course. Painful stimuli trigger a cascade of events that activate the N-methyl-D-aspartate (NMDA) receptor, inducing an increase in oxidative stress. Since there is no effective treatment for this condition, dapsone (4,4'diaminodiphenylsulfone) is proposed as potential treatment for NP. Its anti-oxidant, neuroprotective, and anti-inflammatory properties have been documented, however, there is no evidence regarding its use for treatment of NP induced by SCI.
In this study, we evaluated the anti-allodynic and anti-hyperalgesic effect of dapsone as preventive or acute treatment after NP was already established. Furthermore, participation of oxidative stress was evaluated by measuring lipid peroxidation (LP) and glutathione concentration (GSH) in rats with SCI.
Acute treatment with dapsone (3.1-25 mg/kg, i.p.) decreased nociceptive behaviors in a dose-dependent manner, decreased LP, and increased GSH in the injured tissue 15 days after the injury was produced. On the other hand, preventive treatment (3 h post-injury, once daily for 3 days) with dapsone (3.1-25 mg/kg, i.p.) yielded similar results.
The findings suggest that the anti-nociceptive effect of dapsone is regulated through the decrease of oxidative stress and the excitotoxicity is associated with the activation of NMDA receptors.Level of Evidence: N/A.
前瞻性纵向实验研究。
我们评估了氨苯砜对触觉过敏和机械性痛觉过敏的影响,并确定其在大鼠脊髓损伤(SCI)模型中的抗氧化作用。
创伤性脊髓损伤引起的神经性疼痛(NP)是一种具有时间或永久性病程的有害疾病。疼痛刺激引发一系列事件,激活 N-甲基-D-天冬氨酸(NMDA)受体,导致氧化应激增加。由于对此病症没有有效的治疗方法,因此提出氨苯砜(4,4'-二氨基二苯砜)作为 NP 的潜在治疗方法。其抗氧化、神经保护和抗炎特性已得到证实,然而,尚无关于其用于治疗 SCI 引起的 NP 的证据。
在这项研究中,我们评估了氨苯砜的抗敏作用和抗痛觉过敏作用,作为 NP 已经确立后的预防或急性治疗。此外,通过测量脊髓损伤大鼠的脂质过氧化(LP)和谷胱甘肽浓度(GSH)来评估氧化应激的参与。
急性给予氨苯砜(3.1-25mg/kg,腹腔注射)可剂量依赖性地降低伤害性行为,降低损伤组织中的脂质过氧化产物(LP),并增加谷胱甘肽(GSH)浓度 15 天后。另一方面,预防性治疗(损伤后 3 小时,每天一次,共 3 天)也产生了类似的结果。
研究结果表明,氨苯砜的镇痛作用是通过降低氧化应激来调节的,兴奋性毒性与 NMDA 受体的激活有关。
无。